Cargando…

Impact of type 2 diabetes mellitus on kidney transplant rates and clinical outcomes among waitlisted candidates in a single center European experience

Despite type 2 diabetes mellitus (T2D) is commonly considered a detrimental factor in dialysis, its clear effect on morbidity and mortality on waitlisted patients for kidney transplant (KT) has never been completely elucidated. We performed a retrospective analysis on 714 patients admitted to wait-l...

Descripción completa

Detalles Bibliográficos
Autores principales: Dolla, Caterina, Naso, Erika, Mella, Alberto, Allesina, Anna, Giraudi, Roberta, Torazza, Maria Cristina, Vanzino, Silvia Bruna, Gallo, Ester, Lavacca, Antonio, Fop, Fabrizio, Biancone, Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738492/
https://www.ncbi.nlm.nih.gov/pubmed/33319849
http://dx.doi.org/10.1038/s41598-020-78938-3
_version_ 1783623127275667456
author Dolla, Caterina
Naso, Erika
Mella, Alberto
Allesina, Anna
Giraudi, Roberta
Torazza, Maria Cristina
Vanzino, Silvia Bruna
Gallo, Ester
Lavacca, Antonio
Fop, Fabrizio
Biancone, Luigi
author_facet Dolla, Caterina
Naso, Erika
Mella, Alberto
Allesina, Anna
Giraudi, Roberta
Torazza, Maria Cristina
Vanzino, Silvia Bruna
Gallo, Ester
Lavacca, Antonio
Fop, Fabrizio
Biancone, Luigi
author_sort Dolla, Caterina
collection PubMed
description Despite type 2 diabetes mellitus (T2D) is commonly considered a detrimental factor in dialysis, its clear effect on morbidity and mortality on waitlisted patients for kidney transplant (KT) has never been completely elucidated. We performed a retrospective analysis on 714 patients admitted to wait-list (WL) for their first kidney transplant from 2005 to 2010. Clinical characteristics at registration in WL (age, body mass index -BMI-, duration and modality of dialysis, underlying nephropathy, coronary artery -CAD- and/or peripheral vascular disease), mortality rates, and effective time on WL were investigated and compared according to T2D status (presence/absence). Data about therapy and management of T2D were also considered. At the time of WL registration T2D patients (n = 86) were older than non-T2D (n = 628) (58.7 ± 8.6 years vs 51.3 ± 12.9) with higher BMI (26.2 ± 3.8 kg/m(2) vs 23.8 ± 3.6), more frequent history of CAD (33.3% vs 9.8%) and peripheral vascular disease (25.3% vs 5.8%) (p < 0.001 for all analyses). Considering overall population, T2D patients had reduced survival vs non-T2D (p < 0.001). Transplanted patients showed better survival in both T2D and non-T2D groups despite transplant rate are lower in T2D (75.6% vs 85.8%, p < 0.001). T2D was also associated to similar waiting time but longer periods between dialysis start and registration in WL (1.6 years vs 1.2, p = 0.008), comorbidity-related suspension from WL (571 days vs 257, p = 0.002), and increased mortality rate (33.7% vs 13.9% in the overall population, p < 0.001). In T2D patients admitted to WL, an history of vascular disease was significantly associated to low patient survival (p = 0.019). In conclusion, T2D significantly affects survival also on waitlisted patients. Allocation policies in T2D patients may be adjusted according to increased risk of mortality and WL suspension due to comorbidities.
format Online
Article
Text
id pubmed-7738492
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-77384922020-12-17 Impact of type 2 diabetes mellitus on kidney transplant rates and clinical outcomes among waitlisted candidates in a single center European experience Dolla, Caterina Naso, Erika Mella, Alberto Allesina, Anna Giraudi, Roberta Torazza, Maria Cristina Vanzino, Silvia Bruna Gallo, Ester Lavacca, Antonio Fop, Fabrizio Biancone, Luigi Sci Rep Article Despite type 2 diabetes mellitus (T2D) is commonly considered a detrimental factor in dialysis, its clear effect on morbidity and mortality on waitlisted patients for kidney transplant (KT) has never been completely elucidated. We performed a retrospective analysis on 714 patients admitted to wait-list (WL) for their first kidney transplant from 2005 to 2010. Clinical characteristics at registration in WL (age, body mass index -BMI-, duration and modality of dialysis, underlying nephropathy, coronary artery -CAD- and/or peripheral vascular disease), mortality rates, and effective time on WL were investigated and compared according to T2D status (presence/absence). Data about therapy and management of T2D were also considered. At the time of WL registration T2D patients (n = 86) were older than non-T2D (n = 628) (58.7 ± 8.6 years vs 51.3 ± 12.9) with higher BMI (26.2 ± 3.8 kg/m(2) vs 23.8 ± 3.6), more frequent history of CAD (33.3% vs 9.8%) and peripheral vascular disease (25.3% vs 5.8%) (p < 0.001 for all analyses). Considering overall population, T2D patients had reduced survival vs non-T2D (p < 0.001). Transplanted patients showed better survival in both T2D and non-T2D groups despite transplant rate are lower in T2D (75.6% vs 85.8%, p < 0.001). T2D was also associated to similar waiting time but longer periods between dialysis start and registration in WL (1.6 years vs 1.2, p = 0.008), comorbidity-related suspension from WL (571 days vs 257, p = 0.002), and increased mortality rate (33.7% vs 13.9% in the overall population, p < 0.001). In T2D patients admitted to WL, an history of vascular disease was significantly associated to low patient survival (p = 0.019). In conclusion, T2D significantly affects survival also on waitlisted patients. Allocation policies in T2D patients may be adjusted according to increased risk of mortality and WL suspension due to comorbidities. Nature Publishing Group UK 2020-12-15 /pmc/articles/PMC7738492/ /pubmed/33319849 http://dx.doi.org/10.1038/s41598-020-78938-3 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Dolla, Caterina
Naso, Erika
Mella, Alberto
Allesina, Anna
Giraudi, Roberta
Torazza, Maria Cristina
Vanzino, Silvia Bruna
Gallo, Ester
Lavacca, Antonio
Fop, Fabrizio
Biancone, Luigi
Impact of type 2 diabetes mellitus on kidney transplant rates and clinical outcomes among waitlisted candidates in a single center European experience
title Impact of type 2 diabetes mellitus on kidney transplant rates and clinical outcomes among waitlisted candidates in a single center European experience
title_full Impact of type 2 diabetes mellitus on kidney transplant rates and clinical outcomes among waitlisted candidates in a single center European experience
title_fullStr Impact of type 2 diabetes mellitus on kidney transplant rates and clinical outcomes among waitlisted candidates in a single center European experience
title_full_unstemmed Impact of type 2 diabetes mellitus on kidney transplant rates and clinical outcomes among waitlisted candidates in a single center European experience
title_short Impact of type 2 diabetes mellitus on kidney transplant rates and clinical outcomes among waitlisted candidates in a single center European experience
title_sort impact of type 2 diabetes mellitus on kidney transplant rates and clinical outcomes among waitlisted candidates in a single center european experience
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738492/
https://www.ncbi.nlm.nih.gov/pubmed/33319849
http://dx.doi.org/10.1038/s41598-020-78938-3
work_keys_str_mv AT dollacaterina impactoftype2diabetesmellitusonkidneytransplantratesandclinicaloutcomesamongwaitlistedcandidatesinasinglecentereuropeanexperience
AT nasoerika impactoftype2diabetesmellitusonkidneytransplantratesandclinicaloutcomesamongwaitlistedcandidatesinasinglecentereuropeanexperience
AT mellaalberto impactoftype2diabetesmellitusonkidneytransplantratesandclinicaloutcomesamongwaitlistedcandidatesinasinglecentereuropeanexperience
AT allesinaanna impactoftype2diabetesmellitusonkidneytransplantratesandclinicaloutcomesamongwaitlistedcandidatesinasinglecentereuropeanexperience
AT giraudiroberta impactoftype2diabetesmellitusonkidneytransplantratesandclinicaloutcomesamongwaitlistedcandidatesinasinglecentereuropeanexperience
AT torazzamariacristina impactoftype2diabetesmellitusonkidneytransplantratesandclinicaloutcomesamongwaitlistedcandidatesinasinglecentereuropeanexperience
AT vanzinosilviabruna impactoftype2diabetesmellitusonkidneytransplantratesandclinicaloutcomesamongwaitlistedcandidatesinasinglecentereuropeanexperience
AT galloester impactoftype2diabetesmellitusonkidneytransplantratesandclinicaloutcomesamongwaitlistedcandidatesinasinglecentereuropeanexperience
AT lavaccaantonio impactoftype2diabetesmellitusonkidneytransplantratesandclinicaloutcomesamongwaitlistedcandidatesinasinglecentereuropeanexperience
AT fopfabrizio impactoftype2diabetesmellitusonkidneytransplantratesandclinicaloutcomesamongwaitlistedcandidatesinasinglecentereuropeanexperience
AT bianconeluigi impactoftype2diabetesmellitusonkidneytransplantratesandclinicaloutcomesamongwaitlistedcandidatesinasinglecentereuropeanexperience